Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Acute Heart Failure (AHF) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Acute Heart Failure (AHF) Therapeuticsmarket, defines the market attractiveness level of Acute Heart Failure (AHF) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Acute Heart Failure (AHF) Therapeutics industry, describes the types of Acute Heart Failure (AHF) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acute Heart Failure (AHF) Therapeutics market and the development prospects and opportunities of Acute Heart Failure (AHF) Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acute Heart Failure (AHF) Therapeutics market in Chapter 13.
By Player:
Merck & Co
PhaseBio Pharmaceuticals, Inc
Novartis AG
Bayer AG
Bristol-Myers Squibb Company
Cytokinetics, Inc
Orion Corporation
Cardiorentis AG
CVie Therapeutics Limited
By Type:
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others
By End-User:
Hospital
Clinic
Home Care
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Acute Heart Failure (AHF) Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Acute Heart Failure (AHF) Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Acute Heart Failure (AHF) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Acute Heart Failure (AHF) Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Acute Heart Failure (AHF) Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Acute Heart Failure (AHF) Therapeutics Consumption (2017-2022)
-
7.2 United States Acute Heart Failure (AHF) Therapeutics Consumption (2017-2022)
-
7.3 Europe Acute Heart Failure (AHF) Therapeutics Consumption (2017-2022)
-
7.4 China Acute Heart Failure (AHF) Therapeutics Consumption (2017-2022)
-
7.5 Japan Acute Heart Failure (AHF) Therapeutics Consumption (2017-2022)
-
7.6 India Acute Heart Failure (AHF) Therapeutics Consumption (2017-2022)
-
7.7 South Korea Acute Heart Failure (AHF) Therapeutics Consumption (2017-2022)
8 Region and Country-wise Acute Heart Failure (AHF) Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Acute Heart Failure (AHF) Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Acute Heart Failure (AHF) Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Acute Heart Failure (AHF) Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Acute Heart Failure (AHF) Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Acute Heart Failure (AHF) Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Acute Heart Failure (AHF) Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Acute Heart Failure (AHF) Therapeutics Consumption Forecast (2022-2028)
9 Global Acute Heart Failure (AHF) Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Acute Heart Failure (AHF) Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global B-Blockers Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Calcium Channel Blockers Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cardiac Glycosides Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Diuretics Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Morphine Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Vasodilators/Nitrates Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Acute Heart Failure (AHF) Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)
10 Global Acute Heart Failure (AHF) Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Acute Heart Failure (AHF) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global B-Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Calcium Channel Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Cardiac Glycosides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Diuretics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Morphine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Vasodilators/Nitrates Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Acute Heart Failure (AHF) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)
11 Global Acute Heart Failure (AHF) Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Acute Heart Failure (AHF) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Acute Heart Failure (AHF) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Acute Heart Failure (AHF) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Acute Heart Failure (AHF) Therapeutics Market Competitive Analysis
-
14.1 Merck & Co
-
14.1.1 Merck & Co Company Details
-
14.1.2 Merck & Co Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck & Co Acute Heart Failure (AHF) Therapeutics Product and Service
-
14.2 PhaseBio Pharmaceuticals, Inc
-
14.2.1 PhaseBio Pharmaceuticals, Inc Company Details
-
14.2.2 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Acute Heart Failure (AHF) Therapeutics Product and Service
-
14.4 Bayer AG
-
14.4.1 Bayer AG Company Details
-
14.4.2 Bayer AG Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer AG Acute Heart Failure (AHF) Therapeutics Product and Service
-
14.5 Bristol-Myers Squibb Company
-
14.5.1 Bristol-Myers Squibb Company Company Details
-
14.5.2 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Product and Service
-
14.6 Cytokinetics, Inc
-
14.6.1 Cytokinetics, Inc Company Details
-
14.6.2 Cytokinetics, Inc Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Cytokinetics, Inc Acute Heart Failure (AHF) Therapeutics Product and Service
-
14.7 Orion Corporation
-
14.7.1 Orion Corporation Company Details
-
14.7.2 Orion Corporation Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Orion Corporation Acute Heart Failure (AHF) Therapeutics Product and Service
-
14.8 Cardiorentis AG
-
14.8.1 Cardiorentis AG Company Details
-
14.8.2 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Product and Service
-
14.9 CVie Therapeutics Limited
-
14.9.1 CVie Therapeutics Limited Company Details
-
14.9.2 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Acute Heart Failure (AHF) Therapeutics
-
Figure Acute Heart Failure (AHF) Therapeutics Picture
-
Table Global Acute Heart Failure (AHF) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Heart Failure (AHF) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Heart Failure (AHF) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Acute Heart Failure (AHF) Therapeutics Consumption by Country (2017-2022)
-
Figure United States Acute Heart Failure (AHF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Acute Heart Failure (AHF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Acute Heart Failure (AHF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Acute Heart Failure (AHF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Acute Heart Failure (AHF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Acute Heart Failure (AHF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Heart Failure (AHF) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Acute Heart Failure (AHF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Acute Heart Failure (AHF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Acute Heart Failure (AHF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Acute Heart Failure (AHF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Acute Heart Failure (AHF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Acute Heart Failure (AHF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global B-Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Calcium Channel Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiac Glycosides Consumption and Growth Rate (2017-2022)
-
Figure Global Diuretics Consumption and Growth Rate (2017-2022)
-
Figure Global Morphine Consumption and Growth Rate (2017-2022)
-
Figure Global Vasodilators/Nitrates Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Home Care Consumption and Growth Rate (2017-2022)
-
Figure Global B-Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcium Channel Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiac Glycosides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diuretics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Morphine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vasodilators/Nitrates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Acute Heart Failure (AHF) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Acute Heart Failure (AHF) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Acute Heart Failure (AHF) Therapeutics Product and Service
-
Table PhaseBio Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)
-
Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Acute Heart Failure (AHF) Therapeutics Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Acute Heart Failure (AHF) Therapeutics Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Product and Service
-
Table Cytokinetics, Inc (Foundation Year, Company Profile and etc.)
-
Table Cytokinetics, Inc Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cytokinetics, Inc Acute Heart Failure (AHF) Therapeutics Product and Service
-
Table Orion Corporation (Foundation Year, Company Profile and etc.)
-
Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Product and Service
-
Table Cardiorentis AG (Foundation Year, Company Profile and etc.)
-
Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Product and Service
-
Table CVie Therapeutics Limited (Foundation Year, Company Profile and etc.)
-
Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Product and Service
-
